New results from the phase 1b CodeBreaK 101 trial reported at the World Conference on Lung Cancer (WCLC) found that out of 20 patients treated with Lumakras (sotorasib) alongside chemotherapy with ...
who presented the data at the World Conference on Lung cancer (WCLC). Dato-DXd is heading for a decision in December from the FDA based on the Tropion-Lung01 data, with the jury out on its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback